Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 233

1.

FOXL2 Mutation is Absent in Uterine Tumors Resembling Ovarian Sex Cord Tumors.

Chiang S, Staats PN, Senz J, Kommoss F, De Nictolis M, Huntsman DG, Gilks CB, Oliva E.

Am J Surg Pathol. 2015 Jan 9. [Epub ahead of print]

PMID:
25581731
[PubMed - as supplied by publisher]
2.

Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy.

Kwon JS, McAlpine JN, Hanley GE, Finlayson SJ, Cohen T, Miller DM, Gilks CB, Huntsman DG.

Obstet Gynecol. 2015 Feb;125(2):338-45. doi: 10.1097/AOG.0000000000000630.

PMID:
25568991
[PubMed - in process]
3.

Loss of Sprouty2 in human high-grade serous ovarian carcinomas promotes EGF-induced E-cadherin down-regulation and cell invasion.

So WK, Cheng JC, Fan Q, Wong AS, Huntsman DG, Gilks CB, Leung PC.

FEBS Lett. 2015 Jan 30;589(3):302-9. doi: 10.1016/j.febslet.2014.12.012. Epub 2014 Dec 20.

PMID:
25533808
[PubMed - in process]
4.

Incidental Nonuterine High-grade Serous Carcinomas Arise in the Fallopian Tube in Most Cases: Further Evidence for the Tubal Origin of High-grade Serous Carcinomas.

Gilks CB, Irving J, Köbel M, Lee C, Singh N, Wilkinson N, McCluggage WG.

Am J Surg Pathol. 2014 Dec 16. [Epub ahead of print]

PMID:
25517954
[PubMed - as supplied by publisher]
5.

Human epidermal growth factor receptor 2 testing in primary breast cancer in the era of standardized testing: a Canadian prospective study.

Hanna WM, Barnes PJ, Chang MC, Gilks CB, Magliocco AM, Rees H, Quenneville L, Robertson SJ, SenGupta SK, Nofech-Mozes S.

J Clin Oncol. 2014 Dec 10;32(35):3967-73. doi: 10.1200/JCO.2014.55.6092. Epub 2014 Nov 10.

PMID:
25385731
[PubMed - in process]
6.

HER2/neu testing in gastric cancer by immunohistochemistry: assessment of interlaboratory variation.

Sheffield BS, Garratt J, Kalloger SE, Li-Chang HH, Torlakovic EE, Gilks CB, Schaeffer DF.

Arch Pathol Lab Med. 2014 Nov;138(11):1495-502. doi: 10.5858/arpa.2013-0604-OA.

PMID:
25357111
[PubMed - in process]
7.

Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee for High Complexity Testing/Immunohistochemistry: guidelines for the preparation, release, and storage of unstained archived diagnostic tissue sections for immunohistochemistry.

Cheung CC, Banerjee D, Barnes PJ, Berendt RC, Butany J, Canil S, Clarke BA, El-Zimaity H, Garratt J, Geldenhuys L, Gilks CB, Manning L, Mengel M, Perez-Ordonez B, Pilavdzic D, Riddell R, Swanson PE, Torlakovic EE.

Am J Clin Pathol. 2014 Nov;142(5):629-33. doi: 10.1309/AJCP77GXYVEQXMXT.

PMID:
25319977
[PubMed - indexed for MEDLINE]
8.

Targeted mutation analysis of endometrial clear cell carcinoma.

Hoang LN, McConechy MK, Meng B, McIntyre JB, Ewanowich C, Gilks CB, Huntsman DG, Köbel M, Lee CH.

Histopathology. 2014 Oct 12. doi: 10.1111/his.12581. [Epub ahead of print]

PMID:
25308272
[PubMed - as supplied by publisher]
9.

Current morphologic criteria perform poorly in identifying hereditary leiomyomatosis and renal cell carcinoma syndrome-associated uterine leiomyomas.

Alsolami S, El-Bahrawy M, Kalloger SE, AlDaoud N, Pathak TB, Cheung CT, Mulligan AM, Tomlinson IP, Pollard PJ, Gilks CB, McCluggage WG, Clarke BA.

Int J Gynecol Pathol. 2014 Nov;33(6):560-7. doi: 10.1097/PGP.0000000000000091.

PMID:
25272294
[PubMed - in process]
10.

Immunohistochemical survey of mismatch repair protein expression in uterine sarcomas and carcinosarcomas.

Hoang LN, Ali RH, Lau S, Gilks CB, Lee CH.

Int J Gynecol Pathol. 2014 Sep;33(5):483-91. doi: 10.1097/PGP.0b013e31829ff239.

PMID:
25083964
[PubMed - in process]
11.

TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data.

Ha G, Roth A, Khattra J, Ho J, Yap D, Prentice LM, Melnyk N, McPherson A, Bashashati A, Laks E, Biele J, Ding J, Le A, Rosner J, Shumansky K, Marra MA, Gilks CB, Huntsman DG, McAlpine JN, Aparicio S, Shah SP.

Genome Res. 2014 Nov;24(11):1881-93. doi: 10.1101/gr.180281.114. Epub 2014 Jul 24.

PMID:
25060187
[PubMed - in process]
Free PMC Article
12.

Absence of BRCA/FMR1 correlations in women with ovarian cancers.

Gleicher N, McAlpine JN, Gilks CB, Kushnir VA, Lee HJ, Wu YG, Lazzaroni-Tealdi E, Barad DH.

PLoS One. 2014 Jul 18;9(7):e102370. doi: 10.1371/journal.pone.0102370. eCollection 2014.

PMID:
25036526
[PubMed - in process]
Free PMC Article
13.

The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.

Chui MH, Ryan P, Radigan J, Ferguson SE, Pollett A, Aronson M, Semotiuk K, Holter S, Sy K, Kwon JS, Soma A, Singh N, Gallinger S, Shaw P, Arseneau J, Foulkes WD, Gilks CB, Clarke BA.

Am J Surg Pathol. 2014 Sep;38(9):1173-81. doi: 10.1097/PAS.0000000000000298.

PMID:
25025451
[PubMed - indexed for MEDLINE]
14.

Expanding the Morphologic Spectrum of Differentiated VIN (dVIN) Through Detailed Mapping of Cases With p53 Loss.

Singh N, Leen SL, Han G, Faruqi A, Kokka F, Rosenthal A, Jiang XR, Kim R, McAlpine JN, Gilks CB.

Am J Surg Pathol. 2015 Jan;39(1):52-60. doi: 10.1097/PAS.0000000000000291.

PMID:
25025443
[PubMed - in process]
15.

Mutations in oncogenes: context matters.

Gilks CB.

Gynecol Oncol. 2014 Jul;134(1):1-2. doi: 10.1016/j.ygyno.2014.05.023. No abstract available.

PMID:
24952407
[PubMed - indexed for MEDLINE]
16.

Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal.

Singh N, Gilks CB, Wilkinson N, McCluggage WG.

Histopathology. 2014 Aug;65(2):149-54. doi: 10.1111/his.12419. Epub 2014 May 20.

PMID:
24660659
[PubMed - in process]
17.

Better therapeutic trials in ovarian cancer.

Bookman MA, Gilks CB, Kohn EC, Kaplan KO, Huntsman D, Aghajanian C, Birrer MJ, Ledermann JA, Oza AM, Swenerton KD.

J Natl Cancer Inst. 2014 Apr;106(4):dju029. doi: 10.1093/jnci/dju029. Epub 2014 Mar 13. Review.

PMID:
24627272
[PubMed - indexed for MEDLINE]
18.

Comparison of molecular abnormalities in vulvar and vaginal melanomas.

Aulmann S, Sinn HP, Penzel R, Gilks CB, Schott S, Hassel JC, Schmidt D, Kommoss F, Schirmacher P, Kommoss S.

Mod Pathol. 2014 Oct;27(10):1386-93. doi: 10.1038/modpathol.2013.211. Epub 2014 Mar 7.

PMID:
24603591
[PubMed - in process]
19.

Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.

McAlpine JN, Hanley GE, Woo MM, Tone AA, Rozenberg N, Swenerton KD, Gilks CB, Finlayson SJ, Huntsman DG, Miller DM; Ovarian Cancer Research Program of British Columbia.

Am J Obstet Gynecol. 2014 May;210(5):471.e1-11. doi: 10.1016/j.ajog.2014.01.003. Epub 2014 Jan 9.

PMID:
24412119
[PubMed - indexed for MEDLINE]
20.

Patterns of spread of clear cell ovarian cancer: Case report and case series.

Kumar A, Gilks CB, Mar C, Santos J, Tinker AV.

Gynecol Oncol Case Rep. 2013 Aug 3;6:25-7. doi: 10.1016/j.gynor.2013.07.008. eCollection 2013.

PMID:
24371712
[PubMed]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk